Skip to main content
. 2022 Mar 25;11(4):629. doi: 10.3390/antiox11040629

Figure 5.

Figure 5

Effect of the different RNAi (HSP-16.2, SOD-3, SOD-2, SKN-1, and DAF-16) in a paralysis assay in CL4176 worms treated on HOFE at 100 μg/mL. Data are presented as mean ± standard error of the mean. An * means significant differences (p < 0.05) with respect to worms non-exposed to RNAi and treated on HOFE.